QNTM
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
QNTM
14 hedge funds and large institutions have $445K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $527K → $445K (-$82.5K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
14
Holding in Top 10
–
Calls
$61K
Puts
$7K
Top Buyers
| 1 | +$24.6K | |
| 2 | +$5.59K | |
| 3 | +$3.33K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$100 |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$58 |
Top Sellers
| 1 | -$66K | |
| 2 | -$11K | |
| 3 | -$10K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$564 |
| 5 |
Renaissance Technologies
New York
|
-$361 |